Contraception

• CLINICAL_TRIALS withdrawal · 2022-02-16
  Clinical Trial Update: Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017) [Phase 3]

  Phase 3 trial of oral NOMAC-E2 for contraception in Indian women has been withdrawn.

• EMA withdrawal · 2014-08-26
  EMA Withdrawn: Ioa (nomegestrol acetate;estradiol) — Organon N.V.

  EMA has withdrawn the contraceptive product Ioa (nomegestrol acetate and estradiol) from Organon N.V.'s portfolio.